BioSpace News Archive

Press Releases

Kelun-Biotech’s Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of SKB378/WIN378

July 23, 2025
·
3 min read
Press Releases

HBM9378/WIN378, a Long-Acting, Fully Human Anti-TSLP Antibody, Enters Global Phase 2 POLARIS Trial for Asthma

July 23, 2025
·
4 min read
Press Releases

Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025

July 23, 2025
·
2 min read
Press Releases

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

July 23, 2025
·
1 min read
Press Releases

Intelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform Resilience

July 23, 2025
·
5 min read
Press Releases

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

July 23, 2025
·
5 min read
Press Releases

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

July 23, 2025
·
6 min read
Press Releases

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib

July 23, 2025
·
6 min read
Press Releases

Alkeus Pharmaceuticals Announces Gildeuretinol Data Presentations During the American Society of Retina Specialists (ASRS) 43rd Annual Meeting July 29-August 2

July 23, 2025
·
3 min read
Press Releases

Windward Bio Initiates Global Phase 2 Asthma Trial of WIN378, a Potential Best-in-Disease, Long-Acting, Anti-TSLP Monoclonal Antibody

July 23, 2025
·
3 min read